熱門資訊> 正文
共和党众议员劳勒称大麻为反对特朗普重新安排计划的“入门毒品”
2025-12-17 04:04
- Rep. Mike Lawler (R-N.Y.) wants President Trump to think again about potentially rescheduling marijuana to a less harmful drug, calling cannabis a "gateway drug."
- "Most of the people who end up using hard substances start out on marijuana," the lawmaker said Monday on NewsNation's The Hill podcast.
- He added the amount of THC -- the key psychoactive component of cannabis -- in marijuana today is much higher than it was 30 or 40 years ago.
- On Monday, the president confirmed he is looking at issuing an Executive Order moving marijuana to Schedule III from Schedule I under the Controlled Substances Act.
- Most cannabis multi-state operators are up double-digit percentages in Tuesday trading.
- Multi-state operators: Ascend Wellness (OTCQX:AAWH), Curaleaf Holdings (OTCPK:CURLF), Cresco Labs (OTCQX:CRLBF), Green Thumb Industries (OTCQX:GTBIF), Trulieve Cannabis (OTCQX:TCNNF), Ayr Wellness (OTCQX:AYRWF), Verano Holdings (VRNO), and Jushi Holdings (OTCQX:JUSHF).
- Cannabis ETFs: AdvisorShares Pure Cannabis ETF (NYSEARCA:YOLO), Amplify Alternative Harvest ETF (MJUS), and Amplify Seymour Cannabis ETF (NYSEARCA:CNBS).
- Dear readers: We recognize that politics often intersects with the financial news of the day, so we invite you to click here to join the separate political discussion.
More on Curaleaf, Trulieve Cannabis
- Trulieve's Rally Is A Chance To Exit
- Why I'm Buying Curaleaf Before The 2026 Hemp Ban Kicks In
- Curaleaf: Strong Q3 Results, But Volatility Returns To Cannabis Sector
- Trump confirms Executive Order to reclassify marijuana under consideration
- Trump could seek Executive Order to reclassify marijuana - report
風險及免責提示:以上內容僅代表作者的個人立場和觀點,不代表華盛的任何立場,華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前,應結合自身情況,考慮投資產品的風險。必要時,請諮詢專業投資顧問的意見。華盛不提供任何投資建議,對此亦不做任何承諾和保證。